Skip to content

Observational Study on the Effectiveness and Adverse Reactions of Intravenous Induction and Maintenance of Anesthesia with Fospropofol Disodium for Injection in Different Populations

Observational Study on the Effectiveness and Adverse Reactions of Intravenous Induction and Maintenance of Anesthesia with Fospropofol Disodium for Injection in Different Populations

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086571
Enrollment
Unknown
Registered
2024-07-05
Start date
2024-07-08
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing general anesthesia

Interventions

Intervention group (Induction of anesthesia with fospropofol at a dose of 10-20 mg/kg, and maintenance of anesthesia at a dose of 10-15 mg/kg/h.):None
Control group (Induction of anesthesia with propofol at a dose of 1.5-2.5 mg/kg, and maintenance of anesthesia at a dose of 4-10 mg/kg/h.):None

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1)Age = 18 years, gender not limited; (2)Patients scheduled for surgery under general anesthesia; (3)ASA classification I-II; (4)18 kg/m² = BMI = 30 kg/m²; (5)Able to understand the study procedures and communicate effectively with the research staff; (6)Voluntarily participate and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals who have participated in other drug clinical trials within the past 3 months; (2) Individuals with incomplete clinical examination data or deemed unsuitable for this study by the researcher; (3) Individuals with communication barriers (language barriers, mental disorders); (4) Individuals with severe cardiovascular diseases such as atrioventricular block, severe cardiac dysfunction, or cerebral insufficiency; (5) Individuals known to have intolerance or allergy to the experimental drug used in this study; (6) Individuals with peripheral vascular diseases, recent use of antidepressants and hypnotics, or multiple surgical anesthesia experiences; (7) Individuals with a history of neurological disorders: craniocerebral injury, intracranial hypertension, cerebral aneurysm, or history of cerebrovascular accidents.

Design outcomes

Primary

MeasureTime frame
Postoperative cognitive dysfunction;

Secondary

MeasureTime frame
Vital signs during the perioperative period;Patient questionnaire follow-up data;

Countries

China

Contacts

Public ContactZhongyuan Xia

Renmin Hospital of Wuhan University

xiazhongyuan2005@aliyun.com+86 138 0862 8560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026